Innovative Blood Glucose Monitoring System Launched
By LabMedica International staff writers Posted on 13 Sep 2016 |
Image: The Accu-Chek Guide blood glucose meter monitoring system (Photo courtesy of Roche Diagnostics).
The next-generation blood glucose monitoring system has recently been launched and this system is designed to make everyday blood glucose (BG) monitoring easier.
The system is designed with features such as the spill-resistant test strip vial, which helps users to remove just one strip at a time and avoid spillage or contamination and also provides for advanced accuracy, which enables reliable diabetes management.
The Accu-Chek Guide system (Roche Diagnostics, Basel Switzerland) enables on-board pattern detection that helps to increase awareness of too high or too low glucose readings as well as Bluetooth Low Energy connectivity to the Accu-Chek Connect diabetes management solution via a mobile app. This cloud-based solution guarantees a secure online data exchange and automatic data logging. People with diabetes, caregivers, and healthcare providers can share diabetes information virtually anywhere for timely advice and remote monitoring.
Such telemedicine solutions can help people with diabetes and their caregivers manage diabetes more efficiently and give them peace of mind and a feeling of relief. Hence, 97% of 197 participants in a recently published study from France and the USA agreed that the system was very easy to use and offers a better testing experience. The Accu-Chek Guide system not only fulfills current accuracy standards, but delivers even tighter 10/10 accuracy for more reliable results.
Consistently accurate measurements are essential for reliable BG monitoring and deriving the correct therapy decisions. Large deviations of the measured BG values from the true glucose levels can result in higher HbA1c levels, glycemic excursions and markedly increased rates of hypoglycemic events, as a recently published retrospective study revealed. In addition, studies have demonstrated that only about half of the BG meters evaluated meet the minimum accuracy requirements as defined by the ISO standards.
Roland Diggelmann, MBA, CEO of Roche Diagnostics, said, “As the global leader in diabetes management we are dedicated to supporting people with diabetes, in thinking less about their daily therapy routines. We are very excited to introduce this innovative system that simplifies blood glucose monitoring and improves the testing experience.”
Related Links:
Roche Diagnostics
The system is designed with features such as the spill-resistant test strip vial, which helps users to remove just one strip at a time and avoid spillage or contamination and also provides for advanced accuracy, which enables reliable diabetes management.
The Accu-Chek Guide system (Roche Diagnostics, Basel Switzerland) enables on-board pattern detection that helps to increase awareness of too high or too low glucose readings as well as Bluetooth Low Energy connectivity to the Accu-Chek Connect diabetes management solution via a mobile app. This cloud-based solution guarantees a secure online data exchange and automatic data logging. People with diabetes, caregivers, and healthcare providers can share diabetes information virtually anywhere for timely advice and remote monitoring.
Such telemedicine solutions can help people with diabetes and their caregivers manage diabetes more efficiently and give them peace of mind and a feeling of relief. Hence, 97% of 197 participants in a recently published study from France and the USA agreed that the system was very easy to use and offers a better testing experience. The Accu-Chek Guide system not only fulfills current accuracy standards, but delivers even tighter 10/10 accuracy for more reliable results.
Consistently accurate measurements are essential for reliable BG monitoring and deriving the correct therapy decisions. Large deviations of the measured BG values from the true glucose levels can result in higher HbA1c levels, glycemic excursions and markedly increased rates of hypoglycemic events, as a recently published retrospective study revealed. In addition, studies have demonstrated that only about half of the BG meters evaluated meet the minimum accuracy requirements as defined by the ISO standards.
Roland Diggelmann, MBA, CEO of Roche Diagnostics, said, “As the global leader in diabetes management we are dedicated to supporting people with diabetes, in thinking less about their daily therapy routines. We are very excited to introduce this innovative system that simplifies blood glucose monitoring and improves the testing experience.”
Related Links:
Roche Diagnostics
Latest Clinical Chem. News
- 3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
- POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
- Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
- New Blood Testing Method Detects Potent Opioids in Under Three Minutes
- Wireless Hepatitis B Test Kit Completes Screening and Data Collection in One Step
- Pain-Free, Low-Cost, Sensitive, Radiation-Free Device Detects Breast Cancer in Urine
- Spit Test Detects Breast Cancer in Five Seconds
- Electrochemical Sensors with Next-Generation Coating Advances Precision Diagnostics at POC
- First-Of-Its-Kind Handheld Device Accurately Detects Fentanyl in Urine within Seconds
- New Fluorescent Sensor Array Lights up Alzheimer’s-Related Proteins for Earlier Detection
- Automated Mass Spectrometry-Based Clinical Analyzer Could Transform Lab Testing
- Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses
- Non-Invasive Sensor Monitors Changes in Saliva Compositions to Rapidly Diagnose Diabetes
- Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia
- Urine Test for Monitoring Changes in Kidney Health Markers Can Predict New-Onset Heart Failure
- AACC Releases Comprehensive Diabetes Testing Guidelines